Clinical Trials

Accrual Status
Limit to SWOG Trials

647 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed S0030 COLORECTAL 2/1/2003 2/1/2005 48% Published
Closed S0031 Advanced Bladder 2/15/2001 10/15/2002 56% Published
Closed S0032 Advanced Prostate 12/1/2001 6/1/2005 48% Published
Closed S0033 Gastrointestinal Stromal Tumor 12/15/2000 9/1/2001 100% Published
Closed S0101 ESOPHAGEAL 4/15/2001 2/1/2003 100% Published
Closed S0102 ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Neg Stage IV Breast Cancer 5/1/2001 1/1/2004 100% Published
Closed S0106 Phase III Starndard + Mylotarg vs. Standard + Daunomycin/Ara-C for AML Under Age 61 5/15/2004 8/20/2009 93% Published
Closed S0107 PANCREAS 7/1/2001 6/1/2003 100% Published
Closed S0108 NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL 4/15/2001 12/1/2004 87% Published
Closed S0109 Advanced Renal 5/1/2001 2/1/2002 100% Published
Closed S0111 Advanced Prostate 6/15/2001 11/15/2003 100% Published
Closed S0112 Elderly AML 8/1/2001 4/1/2003 100% Published
Closed S0115 Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study 1/1/2004 10/15/2010 95% Published
Closed S0119 Gemcitabine/Irinotecan Untreated Extensive SCLC 1/1/2002 2/15/2003 100% Published
Closed S0120 Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders 6/1/2002 4/1/2011 97% Published
Closed S0124 Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC 11/1/2002 3/1/2007 99% Published
Closed S0126 ZD1839/BAC/Previously-Untreated & Previously-Treated; Selected IIIB & IV 12/1/2001 7/1/2003 100% Published
Closed S0127 GASTRIC AND GE JUNCTION 6/1/2002 8/15/2003 88% Published
Closed S0200 OVARIAN 8/15/2002 12/15/2004 6% Published
Closed S0202 GALLBLADDER AND CHOLANGIOCARCINOMA 9/1/2003 4/1/2005 100% Published
Scroll Table